Crispr's Gene-Editing Therapy Found Effective In Treating Blood Disorders In Early-Stage StudyBenzinga • 11/19/19
CRISPR Therapeutics AG (CRSP) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 10/28/19
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial ResultsGlobeNewsWire • 10/28/19
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in OncologyGlobeNewsWire • 10/15/19
Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth StockThe Motley Fool • 10/02/19
CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019GlobeNewsWire • 09/17/19